Key facts
- Amparo Prosthetics’s last known valuation is $7.3M (Jan 2026).
- It has raised $5.5M; the latest was Later Stage VC ($3.1M) in Jan 2026.
- Notable investors include Respond Accelerator, EIT Health, Maze X, Odin Investments, Save the Children Global Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Amparo Prosthetics
- ·The full record, as it builds
Funding rounds
No funding rounds for Amparo Prosthetics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Amparo Prosthetics
Manufacturer of prosthetic sockets intended to provide a comfortable and durable fit for amputees. The company's product uses a pre-assembled cone and anchor plate to streamline the fabrication process, resulting in a functioning prosthesis that can be assembled easily, enabling amputees to start or continue their rehabilitation without prolonged interruption or time bedridden.
- Sector
- Healthcare
- HQ
- Aylesbury, United Kingdom
- Founded
- 2016
- Employees
- 9
- Website
- amparo-prosthetics.com/
- Ownership
- Privately Held (backing)
Amparo Prosthetics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Amparo Prosthetics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Amparo Prosthetics in its N-PORT filings yet. We sweep new filings monthly.